Aeluma Outlines Path for $30M CHIPS Act Funding and 2027 Capex Plans

Key Facts

1Aeluma outlined a path to receive up to $30M in funding under the U.S. CHIPS Act.

2The company is planning capital expenditures of $10M to $12M for fiscal year 2027.

In a move reflecting the push to bolster domestic semiconductor manufacturing, Aeluma has outlined a strategic path to secure up to $30M in funding under the U.S. CHIPS Act. According to reports, the company is positioning itself to leverage these federal incentives to support its long-term growth and infrastructure goals. This strategy highlights the ongoing trend of tech firms seeking non-dilutive government capital to fund expansion.

Regarding its financial roadmap, the company is planning capital expenditures (capex) between $10M and $12M for the 2027 fiscal year. This planned investment indicates a period of heavy near-term spending aimed at scaling operations. Per market data, investors are weighing these capex requirements against the potential influx of federal support to assess the company's future liquidity and growth trajectory.

At the close of September 15, 2026, ALMU shares stood at $13.13, having traded within a range of $12.56 to $13.31 during that session. With no major upcoming catalysts in the immediate economic calendar for the semiconductor sector, market participants will focus on official updates regarding the CHIPS Act funding status as the primary driver for the stock's performance.